<DOC>
	<DOCNO>NCT00919204</DOCNO>
	<brief_summary>As part global clinical development program AG-013736 , study ongoing ( plan ) cancer patient China . An assessment AG-013736 pharmacokinetics Chinese subject , require Chinese Health Authorities , therefore warrant . In current study single dose pharmacokinetics AG-013736 characterize 3 dos ( 5 mg , 7 mg 10 mg ) .</brief_summary>
	<brief_title>Axitinib Pharmacokinetics Chinese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Axitinib</mesh_term>
	<criteria>Healthy male and/or female ( nonchildbearing potential ) Chinese ( individual currently reside mainland China born China parent Chinese descent ) subject age 18 45 year , inclusive . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . ) Body Mass Index ( BMI ) 19 24 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . A BMI low limit 18.5 kg/m2 may round 19.0 kg/m2 ; BMI upper limit 24.5 kg/m2 may round 24.0 kg/m2 acceptable inclusion . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding Screening . Any condition possibly affect drug absorption ( eg , gastrectomy ) . Drug dependency , positive urine drug screen , alcohol dependency . History regular alcohol consumption exceed 28 unit per week . ( One unit=285 mL beer 25 mL spirit 125 mL wine ) . Use tobacco nicotinecontaining product ( positive urine cotinine test ) . Treatment investigational drug within 3 month ( determine local regulation ) 5 halflives precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>AG-013736 , axitinib , pharmacokinetics , healthy , Chinese</keyword>
</DOC>